Home Frequency of thyroid dysfunction in pediatric patients with congenital heart disease exposed to iodinated contrast media – a long-term observational study
Article
Licensed
Unlicensed Requires Authentication

Frequency of thyroid dysfunction in pediatric patients with congenital heart disease exposed to iodinated contrast media – a long-term observational study

  • Rouven Kubicki ORCID logo EMAIL logo , Jochen Grohmann , Klaus-Georg Kunz , Brigitte Stiller , Karl Otfried Schwab and Natascha van der Werf-Grohmann
Published/Copyright: October 1, 2020

Abstract

Background

The thyroid gland of patients with congenital heart disease may be exposed to large doses of iodine from various sources. We assessed the thyroid response after iodine exposure during conventional angiography in cardiac catheterization and angiographic computer tomography in childhood.

Methods

Retrospective mid- to long-term follow-up of 104 individuals (24% neonates, 51% infants, 25% children) with a median age and body weight of 104 days [0–8 years] and 5.3 kg [1.6–20]. Serum levels of thyroid-stimulating hormone, free triiodthyronine and free thyroxine were evaluated at baseline and after excess iodine. We also assessed risk factors that may affect thyroid dysfunction.

Results

Baseline thyroidal levels were within normal range in all patients. The mean cumulative iodinate contrast load was 6.6 ± 1.6 mL/kg. In fact, 75% had experienced more than one event involving iodine exposure, whose median frequency was three times per patient [1–12]. During the median three years follow-up period [0.5–10], the incidence of thyroid dysfunction was 15.4% (n=16). Those patients developed acquired hypothyroidism (transient n=14, long-lasting n=2 [both died]) with 10 of them requiring temporary replacement therapy for transient thyroid dysfunction, while four patients recovered spontaneously. 88 individuals (84.6%) remained euthyroid. Repeated cardiac interventions, use of drugs that interfere with the thyroid and treatment in the intensive care unit at the index date were strong predictors for acquired thyroid dysfunction.

Conclusions

The incidence of acquired hypothyroidism after iodine excess was 15.4%. However, most patients developed only transient hypothyroidism. Systemic iodine exposure seems to be clinically and metabolically well tolerated during long-term follow-up.


Corresponding author: Rouven Kubicki MD, Department of Congenital Heart Disease and Pediatric Cardiology, University Heart Center Freiburg – Bad Krozingen, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Mathildenstrasse, 179106 Freiburg, Germany, Phone: + 49 (0) 761/270 43230, Fax: + 49 (0) 761/270 44680, E-mail:

Acknowledgments

We are grateful to Carole Cürten for language editing.

  1. Research funding: This research group received no specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

  2. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  3. Competing interests: The authors declare that they have no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical Approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional ethical committee.

References

1. van der Spek, AH, Fliers, E, Boelen, A. The classic pathways of thyroid hormone metabolism. Mol Cell Endocrinol 2017; 458: 29–38. https://doi.org/10.1016/j.mce.2017.01.025.Search in Google Scholar PubMed

2. Kocaaslan Atli, S, Olgac Dundar, N, Bayazit, O, Evirgen Esin, N, Erdogan, U, Catli, G, et al. Auditory event-related potentials demonstrate early cognitive impairment in children with subclinical hypothyroidism. J Pediatr Endocrinol Metab 2019; 32: 689–97. https://doi.org/10.1515/jpem-2018-0463.Search in Google Scholar PubMed

3. van der Sluijs Veer, L, Kempers, MJ, Wiedijk, BM, Last, BF, Grootenhuis, MA, Vulsma, T. Evaluation of cognitive and motor development in toddlers with congenital hypothyroidism diagnosed by neonatal screening. J Dev Behav Pediatr 2012; 33: 633–40. https://doi.org/10.1097/dbp.0b013e3182690727.Search in Google Scholar

4. Kang, SL, Benson, L. Recent advances in cardiac catheterization for congenital heart disease. F1000Res 2018; 7: 370. https://doi.org/10.12688/f1000research.13021.1.Search in Google Scholar PubMed PubMed Central

5. Koukkou, EG, Roupas, ND, Markou, KB. Effect of excess iodine intake on thyroid on human health. Minerva Med 2017; 108: 136–46. https://doi.org/10.23736/S0026-4806.17.04923-0.Search in Google Scholar PubMed

6. Smerdely, P, Lim, A, Boyages, SC, Waite, K, Wu, D, Roberts, V, et al. Topical iodine-containing antiseptics and neonatal hypothyroidism in very-low-birthweight infants. Lancet 1989; 2: 661–4. https://doi.org/10.1016/s0140-6736(89)90903-3.Search in Google Scholar PubMed

7. Ahmet, A, Lawson, ML, Babyn, P, Tricco, AC. Hypothyroidism in neonates post-iodinated contrast media: a systematic review. Acta Paediatr 2009; 98: 1568–74. https://doi.org/10.1111/j.1651-2227.2009.01412.x.Search in Google Scholar PubMed

8. Barr, ML, Chiu, HK, Li, N, Yeh, MW, Rhee, CM, Casillas, J, et al. Thyroid dysfunction in children exposed to iodinated contrast media. J Clin Endocrinol Metab 2016; 101: 2366–70. https://doi.org/10.1210/jc.2016-1330.Search in Google Scholar PubMed PubMed Central

9. Dechant, MJ, van der Werf-Grohmann, N, Neumann, E, Spiekerkoetter, U, Stiller, B, Grohmann, J. Thyroidal response following iodine excess for cardiac catheterisation and intervention in early infancy. Int J Cardiol 2016; 223: 1014–18. https://doi.org/10.1016/j.ijcard.2016.08.292.Search in Google Scholar PubMed

10. Rosenberg, V, Michel, A, Chodick, G, Cheng, Y, Palkowitsch, P, Koren, G, et al. Hypothyroidism in young children following exposure to iodinated contrast media: an observational study and a review of the literature. Pediatr Endocrinol Rev 2018; 16: 256–65. https://doi.org/10.17458/per.vol16.2018.hypothyroidism.Search in Google Scholar PubMed

11. Thaker, VV, Galler, MF, Marshall, AC, Almodovar, MC, Hsu, HW, Addis, CJ, et al. Hypothyroidism in infants with congenital heart disease exposed to excess iodine. J Endocr Soc 2017; 1: 1067–78. https://doi.org/10.1210/js.2017-00174.Search in Google Scholar PubMed PubMed Central

12. Thaker, VV, Leung, AM, Braverman, LE, Brown, RS, Levine, B. Iodine-induced hypothyroidism in full-term infants with congenital heart disease: more common than currently appreciated?. J Clin Endocrinol Metab 2014; 99: 3521–6. https://doi.org/10.1210/jc.2014-1956.Search in Google Scholar PubMed PubMed Central

13. Leeuwen, L, van Heijst, AFJ, van Rosmalen, J, de Rijke, YB, Beurskens, L, Tibboel, D, et al. Changes in thyroid hormone concentrations during neonatal extracorporeal membrane oxygenation. J Perinatol 2017; 37: 906–10. https://doi.org/10.1038/jp.2017.56.Search in Google Scholar PubMed

14. Marwali, EM, Caesa, P, Darmaputri, S, Sani, AA, Roebiono, PS, Fakhri, D, et al. Oral triiodothyronine supplementation decreases low cardiac output syndrome after pediatric cardiac surgery. Pediatr Cardiol 2019; 40: 1238–46. https://doi.org/10.1007/s00246-019-02143-x.Search in Google Scholar PubMed

15. van den Berghe, G. On the neuroendocrinopathy of critical illness. Perspectives for feeding and novel treatments. Am J Respir Crit Care Med 2016; 194: 1337–48. https://doi.org/10.1164/rccm.201607-1516ci.Search in Google Scholar

16. Vargas-Uricoechea, H, Bonelo-Perdomo, A. Thyroid dysfunction and heart failure: mechanisms and associations. Curr Heart Fail Rep 2017; 14: 48–58. https://doi.org/10.1007/s11897-017-0312-5.Search in Google Scholar PubMed

17. Braverman, LE, Ingbar, SH. Changes IN thyroidal function during adaptation to large doses OF iodide. J Clin Invest 1963; 42: 1216–31. https://doi.org/10.1172/jci104807.Search in Google Scholar PubMed PubMed Central

18. Saller, B, Fink, H, Mann, K. Kinetics of acute and chronic iodine excess. Exp Clin Endocrinol Diabetes 1998;106(3 Suppl):S34–8. https://doi.org/10.1055/s-0029-1212044.Search in Google Scholar PubMed

19. Wartofsky, L, Ransil, BJ, Ingbar, SH. Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J Clin Invest 1970; 49: 78–86. https://doi.org/10.1172/jci106225.Search in Google Scholar PubMed PubMed Central

20. Kaplowitz, PB, Jiang, J, Vaidyanathan, P. Radioactive iodine therapy for pediatric Graves’ disease: a single-center experience over a 10-year period. J Pediatr Endocrinol Metab 2020; 33: 383–9 https://doi.org/10.1515/jpem-2019-0316.Search in Google Scholar PubMed

21. Ross, DS, Burch, HB, Cooper, DS, Greenlee, MC, Laurberg, P, Maia, AL, et al. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 2016; 26: 1343–421. https://doi.org/10.1089/thy.2016.0229.Search in Google Scholar PubMed

22. Paulson, JA. Pediatric considerations before, during, and after radiological or nuclear emergencies. Pediatrics 2018; 111: 1455. https://doi.org/10.1542/peds.2018-3000.Search in Google Scholar PubMed

23. Becker, DV, Zanzonico, P. Potassium iodide for thyroid blockade in a reactor accident: administrative policies that govern its use. Thyroid 1997; 7: 193–7. https://doi.org/10.1089/thy.1997.7.193.Search in Google Scholar PubMed

24. Nauman, J, Wolff, J. Iodide prophylaxis in Poland after the Chernobyl reactor accident: benefits and risks. Am J Med 1993; 94: 524–32. https://doi.org/10.1016/0002-9343(93)90089-8.Search in Google Scholar PubMed

25. Jaruratanasirikul, S, Janjindamai, W, Sriplung, H. Congenital hypothyroidism in preterm infants: a 3- to 8-year longitudinal study in southern Thailand. J Pediatr Endocrinol Metab 2019; 32: 1275–82. https://doi.org/10.1515/jpem-2019-0054.Search in Google Scholar PubMed

26. Creo, A, Anderson, H, Cannon, B, Lteif, A, Kumar, S, Tebben, P, et al. Patterns of amiodarone-induced thyroid dysfunction in infants and children: Heart Rhythm; 2019; 16: 1436–42. https://doi.org/10.1016/j.hrthm.2019.03.015.Search in Google Scholar PubMed

27. Gesing, J, Hoppmann, J, Gebauer, R, Pfaffle, R, Bertsche, A, Kiess, W. Diagnosis and clinical course of three adolescents with amiodarone-induced hyperthyroidism. Pediatr Cardiol 2018; 39: 1707–16. https://doi.org/10.1007/s00246-018-1981-x.Search in Google Scholar PubMed

28. Huang, V, Wolf, RM. Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy. J Pediatr Endocrinol Metab 2019; 32: 631–3. https://doi.org/10.1515/jpem-2018-0553.Search in Google Scholar PubMed

29. Martino, E, Bartalena, L, Bogazzi, F, Braverman, LE. The effects of amiodarone on the thyroid. Endocr Rev 2001; 22: 240–54. https://doi.org/10.1210/er.22.2.240.Search in Google Scholar

30. Trudel, K, Sanatani, S, Panagiotopoulos, C. Severe amiodarone-induced hypothyroidism in an infant. Pediatr Crit Care Med 2011; 12: e43–5. https://doi.org/10.1097/pcc.0b013e3181e2a388.Search in Google Scholar

Received: 2020-01-23
Accepted: 2020-08-06
Published Online: 2020-10-01
Published in Print: 2020-11-26

© 2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review Article
  3. The influence of growth hormone therapy on the cardiovascular system in Turner syndrome
  4. Original Articles
  5. Clinical utility of urinary gonadotrophins in hypergonadotrophic states as Turner syndrome
  6. Sclerostin and osteoprotegerin: new markers of chronic kidney disease mediated mineral and bone disease in children
  7. Monthly intravenous alendronate treatment can maintain bone strength in osteogenesis imperfecta patients following cyclical pamidronate treatment
  8. Mechanisms and early patterns of dyslipidemia in pediatric type 1 and type 2 diabetes
  9. Frequency of thyroid dysfunction in pediatric patients with congenital heart disease exposed to iodinated contrast media – a long-term observational study
  10. Effect of growth hormone therapy on thyroid function in isolated growth hormone deficient and short small for gestational age children: a two-year study, including on assessment of the usefulness of the thyrotropin-releasing hormone (TRH) stimulation test
  11. Clinical relevance of T lymphocyte subsets in pediatric Graves’ disease
  12. Long-term follow-up of differentiated thyroid carcinoma in children and adolescents
  13. A quality improvement project for managing hypocalcemia after pediatric total thyroidectomy
  14. Pubertal development and adult height in patients with congenital hypothyroidism detected by neonatal screening in southern Brazil
  15. Clinical characteristics, surgical approach, BRAFV600E mutation and sodium iodine symporter expression in pediatric patients with thyroid carcinoma
  16. BRAFV600E and TERT promoter mutations in paediatric and young adult papillary thyroid cancer and clinicopathological correlation
  17. Case Reports
  18. Pseudohypoparathyroidism type 1B (PHP1B), a rare disorder encountered in adolescence
  19. Impaired glucose homeostasis and a novel HLCS pathogenic variant in holocarboxylase synthetase deficiency: a report of two cases and brief review
  20. Transcobalamin II deficiency in twins with a novel variant in the TCN2 gene: case report and review of literature
  21. Aldosterone deficiency with a hormone profile mimicking pseudohypoaldosteronism
  22. Non-classical lipoid adrenal hyperplasia presenting as hypoglycemic seizures
Downloaded on 3.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2020-0032/html
Scroll to top button